The clinical trial report, “Asthma - Global Clinical Trials Review, 2026" provides an overview of Asthma Clinical trials scenario. This report provides top line data relating to the clinical trials on Asthma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The analyst Clinical Trial Reports are generated using the analyst’s proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Report Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Table of Contents
- Report Guidance
- The analyst Clinical Trials Report Coverage
- Clinical Trials by Region
- Clinical Trials and Average Enrollment by Country
- Top Five Countries Contributing to Clinical Trials in Asia-Pacific
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Top Five Countries Contributing to Clinical Trials in Middle East and Africa
- Top Five Countries Contributing to Clinical Trials in Central and South America
- Clinical Trials by G7 Countries: Proportion of Asthma to Respiratory Clinical Trials
- Clinical Trials in G7 Countries by Trial Status
- Clinical Trials by E7 Countries: Proportion of Asthma to Respiratory Clinical Trials
- Clinical Trials by Phase in E7 Countries
- Clinical Trials in E7 Countries by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Clinical Trials by End Point Status
- Subjects Recruited Over a Period of Time
- Clinical Trials by Sponsor Type
- Prominent Sponsors
- Top Companies Participating in Asthma Therapeutics Clinical Trials
- Prominent Drugs
- Latest Clinical Trials News on Asthma
- Apr 28, 2026: Breztri approved in the US for asthma as first and only triple therapy for patients 12 years of age and older
- Apr 17, 2026: Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference
- Apr 07, 2026: Sanofi’s bispecific scores in respiratory diseases but fails in eczema
- Apr 02, 2026: Sitryx Nominates Novel, Oral GLS1 Inhibitor for Clinical Development in Moderate to Severe Asthma
- Mar 30, 2026: Enanta Pharmaceuticals to Present Data for Its STAT6 Inhibitor Program at IMMUNOLOGY2026, the Annual Meeting of the AAI
- Mar 30, 2026: Connect Biopharma Announces Positive Topline Data from Its Phase 1 Study of Intravenous (IV) Rademikibart in Patients with Asthma or COPD
- Mar 22, 2026: Harbour Biomed Reports the Online Publication of Phase I Results for HBM9378 (SKB378/WIN378), a TSLP-Targeting Antibody
- Mar 10, 2026: Pfizer’s trispecific heads to Phase III on mid-stage AD success
- Mar 05, 2026: CSPC Pharmaceutical Announces Indacaterol Acetate and Mometasone Furoate Powder For Inhalation Obtains Clinical Trial Approval in China
- Mar 03, 2026: Vial Doses First Patient for Phase 1 Trial of Vial’s IL-13 x TSLP, a Novel Bispecific Antibody
- Feb 24, 2026: Aclaris Therapeutics Initiates Phase 1B Proof-Of-Concept Trial in Patients with Asthma with Its Novel Bispecific Anti-TSLP/Il-4ra Antibody ATI-052
- Feb 18, 2026: GSK’s AREXVY Associated With Reductions in Certain RSV-Related Risks Including Heart Attack, Stroke and Severe Flare-Ups of COPD and Asthma
- Feb 13, 2026: Positive and Clinically Meaningful Results From Phase III Trials for Breztri in Patients With Asthma Published in Lancet Respiratory Medicine
- Feb 12, 2026: Upstream Bio’s stock drops 47% on verekitug Phase II asthma data
- Feb 11, 2026: Akeso's IL-4Ra/ST2 Bispecific Antibody Cleared for Seven Phase II Studies in China Spanning Respiratory and Autoimmune Indications
- Feb 10, 2026: Upstream Bio to Host Webcast to Report Top-Line Results from the Phase 2 VALIANT Trial of Verekitug in Patients with Severe Asthma
- Jan 29, 2026: Kymera Therapeutics Announces First Patient Dosed in Breadth Phase 2B Asthma Clinical Trial of KT-621, a First-In-Class, Oral STAT6 Degrader
- Clinical Trial Profile Snapshots
- Appendix
- Abbreviations
- Definitions
- Research Methodology
- Secondary Research
- About the Analyst
- Contact the Publisher
- Source
- Asthma Therapeutics, Global, Clinical Trials by Region, 2026*
- Asthma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2026*
- Asthma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2026*
- Asthma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2026*
- Asthma Therapeutics Clinical Trials, Europe, Top Five Countries, 2026*
- Asthma Therapeutics Clinical Trials, North America, Top Countries, 2026*
- Asthma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2026*
- Asthma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2026*
- Proportion of Asthma to Respiratory Clinical Trials, G7 Countries (%), 2026*
- Asthma Therapeutics, G7 Countries, Clinical Trials by Phase, 2026*
- Asthma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2026*
- Proportion of Asthma to Respiratory Clinical Trials, E7 Countries (%), 2026*
- Asthma Therapeutics, E7 Countries, Clinical Trials by Phase, 2026*
- Asthma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2026*
- Asthma Therapeutics, Global, Clinical Trials by Phase, 2026*
- Asthma Therapeutics, Global, Clinical Trials In Progress by Phase 2026*
- Asthma Therapeutics, Global, Clinical Trials by Trial Status, 2026*
- Asthma Therapeutics Clinical Trials, Global, by End Point Status, 2026*
- Asthma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2021-2025
- Asthma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2026*
- Asthma Therapeutics Clinical Trials, Global, Key Sponsors, 2026*
- Asthma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2026*
- Asthma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2026*
- Asthma Therapeutics, Global, Clinical Trials by Region (%), 2026*
- Asthma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2026*
- Asthma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2026*
- Asthma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2026*
- Asthma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2026*
- Asthma Therapeutics Clinical Trials, North America, Top Countries (%), 2026*
- Asthma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2026*
- Asthma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2026*
- Proportion of Asthma to Respiratory Clinical Trials, G7 Countries (%), 2026*
- Asthma Therapeutics, G7 Countries, Clinical Trials by Phase, 2026*
- Asthma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2026*
- Proportion of Asthma to Respiratory Clinical Trials, E7 Countries (%), 2026*
- Asthma Therapeutics, E7 Countries, Clinical Trials by Phase, 2026*
- Asthma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2026*
- Asthma Therapeutics, Global, Clinical Trials by Phase (%), 2026*
- Asthma Therapeutics, Global, Clinical Trials In Progress by Phase, 2026*
- Asthma Therapeutics, Global, Clinical Trials by Trial Status, 2026*
- Asthma Therapeutics Clinical Trials, Global, by End Point Status, 2026*
- Asthma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2021-2025
- Asthma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2026*
- Asthma Therapeutics Clinical Trials, Global, Key Sponsors, 2026*
- Asthma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2026*
- Asthma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2026*
- The analyst Methodology
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AstraZeneca Plc
- GSK plc
- Novartis AG
- Teva Pharmaceutical Industries Ltd
- C. H. Boehringer Sohn AG & Co KG
- Chiesi Farmaceutici SpA
- Parexel International Corp
- Sanofi
- Merck & Co Inc
- Organon & Co
